lufironil has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kayano, K; Kubota, M; Mori, K; Okita, K; Sakaida, I; Takenaka, K | 1 |
| Hironaka, K; Okita, K; Sakaida, I; Uchida, K | 1 |
2 other study(ies) available for lufironil and Disease Models, Animal
| Article | Year |
|---|---|
Prevention of fibrosis reduces enzyme-altered lesions in the rat liver.
Topics: Amino Acids; Animals; Choline Deficiency; Diet; Disease Models, Animal; Glutathione Transferase; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; Procollagen-Proline Dioxygenase; Prodrugs; Pyridines; Rats; Rats, Wistar | 1994 |
Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis.
Topics: Animals; Blotting, Northern; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Liver Cirrhosis, Experimental; Male; Procollagen; Pyridines; Rats; Rats, Wistar; Reference Values; Tissue Inhibitor of Metalloproteinase-1 | 1999 |